As Ozempic and other GLP-1 drugs explode in popularity ... The “trendification” of Ozempic and semaglutide is putting immense pressure on supply chains and creating a dangerous vacuum ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...

Glucagon-like peptide-1 ... semaglutide, modulate LS activity in patients with AUD. Additionally, the observed sex-specific effects in LS GLP-1R expression underscore the need for further ...

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...

GLP-1 drugs have helped ... Analysis is ongoing to compare differences in weight loss, lean mass, and fat mass reduction between those using tirzepatide and those using semaglutide.

A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...

RAs, might offer new ways to reduce dementia risk. Discover the latest research and what it means for Alzheimer's treatment.

According to Okava, dosing every six months or longer supports a "One-and-Done" approach between office visits consistent with the product profile of Vivani's NPM-115, an ultra long-acting GLP-1 ...

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...